Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.190
-0.020 (-1.65%)
Sep 8, 2026, 12:23 PM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $58.6 million as of September 8, 2026. Its market cap has decreased by -31.23% in one year.
Market Cap
58.60M
Enterprise Value
59.97M
Revenue
5.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.19
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 58.60M, an increase of 195.18%. That is a compound annual growth rate of 11.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 58.60M | -38.25% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 120.20M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 66.70M |
| Arch Biopartners | 50.27M |
| BetterLife Pharma | 35.87M |
| Cell Source | 35.13M |
| Vicapsys Life Sciences | 32.37M |